Search results
Results From The WOW.Com Content Network
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman , Jordan in 1978.
Baxter acquired medical device firm Baxa on November 10, 2011. [18] In 2011, Hikma Pharmaceuticals PLC completed the acquisition of Baxter Healthcare Corporation's US generic injectables business (Multi-Source Injectables or MSI). [19] [20] In July 2013, EU antitrust regulators approved Baxter's bid for Sweden's Gambro. [21]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Teva's generic launch comes days after the U.S. Food and Drug Administration tentatively approved London-based Hikma Pharmaceuticals' generic version of Victoza, according to the agency's website.
BOSTON (Reuters) -A division of French advertising company Publicis Groupe SA and drug company Hikma Pharmaceuticals have reached separate settlements worth a collective $500 million to resolve ...
The Beecham Group plc was a British pharmaceutical company.It was once a constituent of the FTSE 100 Index.Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. [1]
Said Samih Taleb Darwazah (born 1957) is a Jordanian heir and business executive. He serves as the chairman and chief executive officer (CEO) of Hikma Pharmaceuticals, the FTSE 100 multinational generic pharmaceutical manufacturer founded by his father.
Zeneca (officially Zeneca Group PLC) was a British multinational pharmaceutical company headquartered in London, United Kingdom.It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange.